hantavirus-DAF interaction inhibitors (Emory University/Emory University Technology Transfer Office)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehantavirus-DAF interaction inhibitors (Emory University/Emory University Technology Transfer Office)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement decay-accelerating factor modulators
TargetsComplement decay-accelerating factor
Therapy Area/IndicationsHantavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmory University
Active IndicationsN/A
Inactive IndicationsHantavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A